Schedule 13G ownership disclosure

Precigen Inc

Common Stock · CUSIP: 74017N105

Event date: 2024-12-31

Filing-level shares
17,683,758
Percent of class
6.53%
  • Patient Capital Management, LLC

    Shares: 17,683,758 · Class: 6.53%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001085146-25-001052
Form type
SCHEDULE 13G/A
Filer
PRECIGEN, INC.
CIK
CIK 1356090
Filed
Feb 12, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub